Gehirn Pharmaceuticals Private Limited
About Gehirn Pharmaceuticals Private Limited
Data last updated:
Gehirn Pharmaceuticals Private Limited is a private limited company based in Jabalpur, Madhya Pradesh, India. It was incorporated on 12 March 2023.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U46909MP2023PTC064775.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Aradhana Chaturvedi and Deepshikha Upadhyay.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 204 Rudraksh Park, Nav Nivesh Colony Jabalpur, Madhya Pradesh, India – 482003.
As per the financials filed for FY 2024, the company reported a revenue of ₹47.38 Lakh. For the same year it recorded a net profit of ₹22,158 (net margin 0.5%) and EBITDA of ₹29,938 (EBITDA margin 0.6%).
Company details
Contact details
Gehirn Pharmaceuticals Private Limited's registered office is in Jabalpur, Madhya Pradesh.
- Registered AddressFlat No. 204 Rudraksh Park, Nav Nivesh Colony Jabalpur, Madhya Pradesh, India – 482003
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Gehirn Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Gehirn Pharmaceuticals Private Limited, buy the company report.
Financials of Gehirn Pharmaceuticals Private Limited
FY 2025 filings availableGehirn Pharmaceuticals Private Limited reported revenue of ₹47.38 Lakh for FY 2024.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹29,938 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹22,158 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 0.6% | |
| Net Profit Margin | 0.5% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Gehirn Pharmaceuticals Private Limited, buy the company report.
Board of directors of Gehirn Pharmaceuticals Private Limited
Gehirn Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aradhana Chaturvedi | Director | 12 Mar 2023 | 3 Years 7 Months | Current |
| Deepshikha Upadhyay | Director | 12 Mar 2023 | 3 Years 7 Months | Current |
Peer comparison
Gehirn Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Organext Pharmaceuticals Private Limited | ₹47.58 Lakh (FY 2025) | 17.0% | Jaipur, Rajasthan, India | |||
| Triumph Pharmaceuticals Private Limited | ₹47.46 Lakh (FY 2025) | 5.0% | Mysore, Karnataka, India | |||
| Gehirn Pharmaceuticals Private Limitedthis company | ₹47.38 Lakh (FY 2024) | ₹22,158 | 0.5% | Jabalpur, Madhya Pradesh, India | ||
| Accurel Pharmaceuticals Private Limited | ₹47.27 Lakh (FY 2025) | -47.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Gehirn Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Gehirn Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Gehirn Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Gehirn Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Gehirn Pharmaceuticals Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Aradhana Chaturvedi was appointed as Director on 12 Mar 2023.
Frequently asked questions
Gehirn Pharmaceuticals is an active private limited company based in Jabalpur, Madhya Pradesh, India. It was incorporated on 12 March 2023 (3+ years old) and is registered under CIN U46909MP2023PTC064775.
Gehirn Pharmaceuticals has 2 current directors:
- Aradhana Chaturvedi - Director
- Deepshikha Upadhyay - Director
The latest financial statements of Gehirn Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Gehirn Pharmaceuticals is U46909MP2023PTC064775. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Gehirn Pharmaceuticals was incorporated on 12 March 2023, making it 3+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Gehirn Pharmaceuticals by revenue are Organext Pharmaceuticals Private Limited, Triumph Pharmaceuticals Private Limited, Accurel Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Aradhana Chaturvedi was appointed as Director on 12 Mar 2023. Deepshikha Upadhyay was appointed as Director on 12 Mar 2023.
The registered office of Gehirn Pharmaceuticals is at Flat No. 204 Rudraksh Park, Nav Nivesh Colony Jabalpur, Madhya Pradesh, India – 482003.
Gehirn Pharmaceuticals can be reached at its registered office: Flat No. 204 Rudraksh Park, Nav Nivesh Colony Jabalpur, Madhya Pradesh, India – 482003.
Gehirn Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Gwalior.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
